1. Home
  2. FPI vs PLRX Comparison

FPI vs PLRX Comparison

Compare FPI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$10.74

Market Cap

473.8M

Sector

Real Estate

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$1.08

Market Cap

69.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FPI
PLRX
Founded
2013
2015
Country
United States
United States
Employees
12
49
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.8M
69.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
FPI
PLRX
Price
$10.74
$1.08
Analyst Decision
Hold
Hold
Analyst Count
1
4
Target Price
N/A
★ $2.67
AVG Volume (30 Days)
★ 571.9K
385.6K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
★ 3.14%
N/A
EPS Growth
N/A
★ 29.97
EPS
★ 0.08
N/A
Revenue
★ $52,178,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$134.50
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.21
$1.02
52 Week High
$13.23
$1.95

Technical Indicators

Market Signals
Indicator
FPI
PLRX
Relative Strength Index (RSI) 60.47 44.02
Support Level $10.77 $1.02
Resistance Level $10.99 $1.37
Average True Range (ATR) 0.19 0.04
MACD -0.03 -0.01
Stochastic Oscillator 54.46 13.64

Price Performance

Historical Comparison
FPI
PLRX

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: